The BPGP@CAP nanoassembly enables targeted delivery of both PTX and CAP into the tumor site through the EPR effect, and precise release of PTX and CAP from BPGP@CAP after intelligently responding to overexpressed cathepsin B in the lysosomes of tumor cells. The gene discussed is CTSB; the disease is neoplasm.